Large-sized hepotocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT)

By Zangos Stephan   Eichler Katrin   Balzer Jörn   Straub Ralf   Hammerstingl Renate   Herzog Christopher   Lehnert Thomas   Heller Mathias   Thalhammer Axel   Mack Martin   Vogl Thomas  

European Radiology, Vol. 17, Iss. 2, 2007-02 ,pp. : 553-563

Springer Publishing Company

Access to resources Recommend Favorite

Imaging biomarkers as surrogate endpoints for drug development

By Richter Wolf  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, Iss. 1, 2006-07 ,pp. : 6-10

Springer Publishing Company

Access to resources Recommend Favorite

Mis-identification of factor inhibitors by diagnostic haemostasis laboratories: recognition of pitfalls and elucidation of strategies. A follow up to a large multicentre evaluation

By Favaloro Emmanuel   Bonar Roslyn   Duncan Elizabeth   Earl Gail   Low Joyce   Aboud Margaret   Just Sarah   Sioufi John   Street Alison   Marsden Katherine  

Pathology, Vol. 39, Iss. 5, 2007-10 ,pp. : 504-511

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Making Mechanistic Connections between Cell Signaling Pathways and Pathological Endpoints

By DAVIS MYRTLE  

Toxicologic Pathology, Vol. 32, Iss. 1, 2004-03 ,pp. : 131-135

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Quantitation of Molecular Endpoints for the Dose-Response Component of Cancer Risk Assessment

By Preston R. Julian  

Toxicologic Pathology, Vol. 30, Iss. 1, 2002-01 ,pp. : 112-116

Ashgate Publishing Ltd

Access to resources Recommend Favorite